Abstract
摘要
相似文献
1
Fostamatinib (Tavalisse) for ITP.用于治疗免疫性血小板减少症的 fostamatinib（Tavalisse）
Med Lett Drugs Ther. 2019 Feb 25;61(1566):28-30.
2
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.福他替尼在临床实践中治疗免疫性血小板减少症的疗效和安全性。
Blood. 2024 Aug 8;144(6):646-656. doi: 10.1182/blood.2024024250.
3
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials.福他替尼治疗难治性免疫性血小板减少症的疗效和安全性：来自随机对照试验的荟萃分析。
Ann Hematol. 2024 Sep;103(9):3357-3368. doi: 10.1007/s00277-024-05824-7. Epub 2024 Jun 10.
4
Fostamatinib for the treatment of chronic immune thrombocytopenia.福他替尼治疗慢性免疫性血小板减少症。
Blood. 2019 May 9;133(19):2027-2030. doi: 10.1182/blood-2018-11-852491. Epub 2019 Feb 25.
5
Fostamatinib for the treatment of immune thrombocytopenia in adults.福他替尼治疗成人免疫性血小板减少症。
Am J Health Syst Pharm. 2019 May 17;76(11):789-794. doi: 10.1093/ajhp/zxz052.
6
Fostamatinib: First Global Approval.福他替尼：全球首次获批。
Drugs. 2018 Jun;78(9):959-963. doi: 10.1007/s40265-018-0927-1.
7
Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study.在免疫性血小板减少症患者中使用 fostamatinib 的治疗：来自西班牙安达卢西亚地区的经验- Fostasur 研究。
Br J Haematol. 2024 May;204(5):1977-1985. doi: 10.1111/bjh.19443. Epub 2024 Apr 3.
8
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.福他替尼治疗成人持续性和慢性免疫性血小板减少症：两项 3 期、随机、安慰剂对照试验的结果。
Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15.
9
Prucalopride succinate, Fostamatinib disodium hexahydrate, Avatrombopag maleate, and Lusutrombopag.琥珀酸普芦卡必利、福斯他替尼二钠六水合物、马来酸阿伐曲泊帕和芦曲泊帕。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):601-604. doi: 10.1016/j.japh.2019.05.013.
10
Fostamatinib for persistent/chronic adult immune thrombocytopenia.福斯他替尼用于成人持续性/慢性免疫性血小板减少症
Immunotherapy. 2018 Jan;10(1):9-25. doi: 10.2217/imt-2017-0097. Epub 2017 Oct 2.
引用本文的文献
1
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization.抑制脾酪氨酸激酶可降低致敏大鼠模型中供体特异性抗体水平。
Sci Rep. 2022 Feb 28;12(1):3330. doi: 10.1038/s41598-022-06413-2.
Zotero 插件